500 related articles for article (PubMed ID: 11657562)
1. Testing drugs in pediatric populations: the FDA mandate.
Tauer CA
Account Res; 1999; 7(1):37-58. PubMed ID: 11657562
[No Abstract] [Full Text] [Related]
2. IRB review of a Phase II randomized clinical trial involving incompetent patients suffering from severe closed head injury.
Prentice ED; Antonson DL; Leibrock LG; Kelso TK; Sears TD
IRB; 1993; 15(5):1-7. PubMed ID: 11659703
[No Abstract] [Full Text] [Related]
3. The changing clinical trials scene: the role of the IRB.
Mitchell SC; Steingrub J
IRB; 1988; 10(4):1-5. PubMed ID: 11650078
[No Abstract] [Full Text] [Related]
4. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
Weijer C
IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
[No Abstract] [Full Text] [Related]
5. Research with radiation and healthy children: greater than minimal risk.
Freeman WL
IRB; 1994; 16(5):1-5. PubMed ID: 11652791
[No Abstract] [Full Text] [Related]
6. FDA revises informed consent regulations for emergency research.
Menasché A; Levine RJ
IRB; 1995; 17(5-6):19-22. PubMed ID: 11653359
[No Abstract] [Full Text] [Related]
7. DHHS internal policies for reviewing research involving children.
Reatig N
IRB; 1981 Jan; 3(1):1-4. PubMed ID: 11661894
[No Abstract] [Full Text] [Related]
8. Constraints on experimentation: protecting children to death.
Holder AR
Yale Law Policy Rev; 1988; 6(1):137-56. PubMed ID: 11650241
[No Abstract] [Full Text] [Related]
9. Research involving children: an interpretation of the new regulations.
Levine RJ
IRB; 1983; 5(4):1-5. PubMed ID: 11649521
[No Abstract] [Full Text] [Related]
10. Ethics lobby forces rethink on growth hormones.
Miller SK
New Sci; 1992 Aug; 135(1834):9. PubMed ID: 11659508
[No Abstract] [Full Text] [Related]
11. The use of normal children as participants in research on therapy.
Gordon B; Prentice E; Reitemeier P
IRB; 1996; 18(3):5-8. PubMed ID: 11654409
[No Abstract] [Full Text] [Related]
12. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
Kobasic DM
J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
[No Abstract] [Full Text] [Related]
13. Problems of drug testing in children in the United States.
Yaffe SJ
Pediatr Pharmacol (New York); 1983; 3(3-4):339-48. PubMed ID: 11659147
[No Abstract] [Full Text] [Related]
14. Can children be enrolled in a placebo-controlled randomized clinical trial of synthetic growth hormone?
Prentice ED; Antonson DL; Jameton A; Graber B; Sears T
IRB; 1989; 11(1):6-10. PubMed ID: 11659085
[No Abstract] [Full Text] [Related]
15. Protection of human subjects.
United States
Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819
[No Abstract] [Full Text] [Related]
16. Informed consent: the FDA's perspective.
Bagley G
Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141
[No Abstract] [Full Text] [Related]
17. Multicenter trials and subject eligibility: should local IRBs play a role?
Freedman B
IRB; 1994; 16(1-2):1-6. PubMed ID: 11652320
[No Abstract] [Full Text] [Related]
18. Monitoring of drug tests is faulted.
Eichenwald K
N Y Times Web; 1998 Jun; ():A14. PubMed ID: 11647564
[No Abstract] [Full Text] [Related]
19. Continuing review of research involving human subjects: approach to the problem and remaining areas of concern.
Gordon B; Prentice E
IRB; 1997; 19(2):8-11. PubMed ID: 11655323
[No Abstract] [Full Text] [Related]
20. An update on the PEG-SOD study involving incompetent subjects: FDA permits an exception to informed consent requirements.
Prentice ED; Antonson DL; Leibrock LG; Prabhu VC; Kelso TK; Sears TD
IRB; 1994; 16(1-2):16-8. PubMed ID: 11652322
[No Abstract] [Full Text] [Related]
[Next] [New Search]
